The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| CG ONCOLOGY INC | COM | 156944100 | 28,902,367 | 915,501 | SH | SOLE | 915,501 | 0 | 0 | ||
| PULMONX CORP | COM | 745848101 | 381,693 | 60,204 | SH | SOLE | 60,204 | 0 | 0 | ||
| RAPID MICRO BIOSYSTEMS INC | CLASS A COM | 75340L104 | 685,275 | 1,038,296 | SH | SOLE | 1,038,296 | 0 | 0 | ||